Eli Lilly (LLY) Income towards Parent Company (2009 - 2026)
Eli Lilly's Income towards Parent Company was $7.1 billion in Q2 2026, up 25.3% from $5.66 billion a year earlier but down 4.1% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Income towards Parent Company (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's Income towards Parent Company was $26.71 billion through Jun 30, 2026, up 93.6% year-over-year; for FY2025, it was $20.64 billion, up 94.9% from FY2024.
- Income towards Parent Company shows a five-year compound annual growth rate of 27.2% (FY2020 to FY2025).
- In earlier years, Income towards Parent Company was $10.59 billion in FY2024 (+102.1%), $5.24 billion in FY2023 (-16.1%), $6.24 billion in FY2022 (+11.9%) and $5.58 billion in FY2021 (-9.9%).
- Quarterly Income towards Parent Company has moved between -$57.4 million (Q3 2023) and $7.4 billion (Q1 2026) over five years.
- Compared with a year earlier, Income towards Parent Company has increased for seven straight quarters, with growth averaging 133.5% over the last seven quarters.
- The best year-over-year quarter for Income towards Parent Company over five years was Q3 2025 (growth of 475.3%); the worst was Q2 2022 (a decline of 31.5%).
- Per Business Quant data, LLY's Income towards Parent Company in the three quarters before Q2 2026 was $7.4 billion (Q1 2026), $6.64 billion (Q4 2025) and $5.58 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.10 Bn |
| Mar 31, 2026 | 7.40 Bn |
| Dec 31, 2025 | 6.64 Bn |
| Sep 30, 2025 | 5.58 Bn |
| Jun 30, 2025 | 5.66 Bn |
| Mar 31, 2025 | 2.76 Bn |
| Dec 31, 2024 | 4.41 Bn |
| Sep 30, 2024 | 970.30 Mn |
| Jun 30, 2024 | 2.97 Bn |
| Mar 31, 2024 | 2.24 Bn |
| Dec 31, 2023 | 2.19 Bn |
| Sep 30, 2023 | -57.40 Mn |
| Jun 30, 2023 | 1.76 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 1.45 Bn |
| Jun 30, 2022 | 952.50 Mn |
| Mar 31, 2022 | 1.90 Bn |
| Dec 31, 2021 | 1.73 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Eli Lilly Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();